As a MedTech Quality professional, you know that you need an eQMS solution. Working in a legacy or paper-based system can significantly impact your team’s overall speed and efficiency, as well as present potential risks due to the manual nature of the process.
However, sometimes the people above you in the organization don’t clearly see the need and are unwilling to make the necessary financial investments in the software.
So, how do you make the case to your executive team that investments in an eQMS will help your organization improve its processes and get safer devices to market? This guide will help you make the business case for the investment.
First, it’s important to recognize that the leaders of your company have competing priorities.
They want to bring innovative and safe medical devices to market, and at the same time, they must control the costs of running the business. What good is having a great product if you end up running out of money?
As a result, executives often deprioritize investments they don’t perceive to help increase revenue or reduce costs.
So your job is to make the case for the investment.
To make the case to your executive team, you must quantify the complete value an eQMS solution will have on the overall company. That value can be demonstrated in several different ways:
Greater Efficiency: The eQMS will require fewer resources than the current system and thus save the company money, especially on expensive external consultants.
Improved Speed: The eQMS will help the team move faster, thus getting quality products to market sooner and generating more revenue for the company.
Reduced Risk: The eQMS will help reduce risk related to non-compliance, which could be a high cost to your business as regulatory warning letters may require months or even years to resolve, eating up precious resources.
Greenlight Guru’s eQMS solution can help companies improve efficiency, move faster, and mitigate risk while delivering high-quality medical devices to market.
An independent study by the research firm Hobson & Company found that Greenlight Guru’s eQMS solution can help MedTech companies in the following ways:
50% reduction in time spent on development and design documentation
75% reduction in QA/RA FTE time spent on mandatory training
50% reduction in time spent preparing for audits
40% reduction in the number of audit findings 25% reduction in time to address audit findings
30% reduction in time spent managing quality events
35% reduction in the number of labor hours needed per recall/return/adverse event
Overall, the study found that a three-year investment in the Greenlight Guru eQMS solution generates positive cash flows in just 2.7 months and a return on investment of 419%.
By showing these stats to your executive team, you can quantify how the investment in Greenlight Guru will benefit your company by saving valuable time and money.
Greenlight Guru has over 1000 customers around the world. Here’s what they have to say about the impact on their business.
See more Greenlight Guru customer stories at www.greenlight.guru/customers.
In the 2023 QMS Grid Report, Greenlight Guru ranked as the leading QMS for the eighteenth consecutive quarter.
Learn more at www.g2.com/categories/medical-qms.
Looking for a design control solution to help you bring safer medical devices to market faster with less risk? Click here to take a quick tour of Greenlight Guru's Medical Device QMS software →
Jeff Perkins is the Chief Marketing Officer at Greenlight Guru. He’s an experienced technology executive having held leadership positions at ParkMobile, Tricentis, PGi, and AutoTrader. Jeff started his career in the NYC ad industry at Saatchi & Saatchi. He received his BA from American University and MBA from Emory...